Genetically reprogramming infection-fighting cells known as CD8 cytotoxic T lymphocytes (CTLs) made them especially efficient at wiping out HIV in laboratory experiments, report researchers at the Albert Einstein College at Yeshiva University in the Bronx, New York.
CTLs play a major role fighting HIV in the body by recognizing and killing CD4 cells that are infected with the virus. When HIV infects CD4 cells, small pieces of viral proteins are displayed on the surface of the cell, allowing CTLs to identify and destroy them. Unfortunately, most people living with HIV do not develop a CTL response that is sufficiently potent to control HIV replication. There are, however, a small group of people living with HIV, known as “elite controllers,” who are able to maintain undetectable viral loads without the help of antiretroviral drugs—sometimes indefinitely.
Harris Goldstein, MD, and his colleagues at Yeshiva University theorized that the CTLs of elite controllers may have special properties that make them particularly good at killing infected CD4 cells. They found that these “super CTLs,” as Dr. Goldstein describes them, had receptors that were able to bind very tightly to infected cells and to recognize the viral proteins on the cell surface.
Dr. Goldstein’s team next isolated some of the genes responsible for these hyper-efficient receptors found on the CTLs from elite HIV controllers. The group then bound the genes to a lentivirus, so that they could be effectively delivered into the nuclei of CTLs that do not naturally carry the genes. Once the CTLs began expressing the more efficient receptors, Dr. Goldstein’s team infused them into mice, along with HIV-infected human cells.
After one week, the researchers report, the infected cells had been almost completely destroyed.
Dr. Goldstein intends to locate other genes responsible for boosting the HIV-fighting effectiveness of super CTLs. This may involve reprogramming CTLs using multiple genes, just as HIV-positive people are currently treated with multiple antiretrovirals at one time.
NEW! Scroll down to comment on this story.
Please click OK to confirm your comment and confirm you accept our posting rules. Note your message will be reviewed by our staff before going live.
Previous Comments:
comments 1 - 7 (of 7 total)
j p, pico, 2008-03-20 07:46:31
Is there any clinical trials on the way and if so how can I take part?
Pitla, South Africa, 2008-03-13 02:37:42
I cannnot wait for this treatment, i am sick and tired of taking this ARV's everyday at the same time the rest of my life, this is burden, even on holidays.May God give this Doctors more courage to do their research
Robert, Miami, 2008-03-12 13:34:42
When will these things be available ? I can't wait!
dave, , 2008-03-12 13:12:18
again i just hope they put a rush on this because as many of you have been reading the articles above..more and more of us are being infected everyday! Theres no time in "taking time" to find a cure..this is an urgent matter!
ithink, nj, 2008-03-11 08:31:47
the piece of hiv foreign protien is inserted on the supercell CD8. auto immune response like asthma is fighting the bodies natural defenses, not genetic. like having the wrong blood transfused. i think
Liyth, , 2008-03-11 02:45:15
This a great acheivement in the hestory of HIV treatment, it could be a new step toward finding a cure for this virus.
wondering?, atl, 2008-03-09 09:50:51
how does this work if u happen to have lupus or other auto diseases?
Beth Benne, RN, is HIV negative, but
the virus has impacted her life. She currently supervises a biannual HIV/AIDS awareness week as
the director of the student health center at Pierce College, a
community commuter school in Woodland Hills, California.
Woman of the Month is supported by exclusive advertising from Gilead.
Overheard in the Women's Forum
"I recently met a guy who is negative. I did tell him about my status and he decided to kiss me anyway (we didn't go further than that). But a day later, he called and said that he actually had a mouth ulcer that time when we kissed and he was very worried. Asked if he can get the virus from me that way. For that moment, I felt so insulted and yet I felt so bad. It was my first time having a contact with a "negative" guy."
